Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Heo, Y.
Right arrow Articles by Lawrence, D. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Heo, Y.
Right arrow Articles by Lawrence, D. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1998 Oxford University Press

other

Differential Effects of Lead and cAMP on Development and Activities of Th1- and Th2-Lymphocytes1

Yong Heo, William T. Lee and David A. Lawrence2

Wadsworth Center, New York State Department of Health Albany, New York 12201

Received December 31, 1997; accepted March 19, 1998

Lead (Pb) is known to have detrimental effects on the central nervous, hematopoietic, renal, and immune systems. Herein, it is demonstrated that Pb can skew T cell reactivities by preferentially enhancing the development of Th2 cells and inhibiting the development of Th1 cells. When naive splenic CD4+ T cells from DO11.10 ovalbumin-specific transgenic (OVA-tg) mice or OVA-tg/RAG2–/– mice were developed in vitro in the presence of Pb, preferential skewing toward Th2 cells was evident. The Pb-driven skewing toward Th2 was blocked significantly in the presence of exogenous IL-12 or anti-IL-4 mAbs. Although Pb and dibutyryl cAMP (dbcAMP) appear to have similar effects on the development and reactivity of Th1 cells, unlike Pb, dbcAMP did not enhance Th2 development/activity. Further evidence of Pb's differential T cell effects was observed, in that regardless of the activation stimuli (Ag/APC; anti-CD3; PMA + ionomycin), the addition of PbCl2 consistently resulted in significant inhibition of IFN{gamma} production by a Th1 clone and in increased IL-4 production by a Th2 clone. In vitro addition of IL-12 overcame Pb's inhibition of Th1 cells. Th1 cells treated with a phosphodiesterase inhibitor had significantly elevated [cAMP]1 levels following anti-CD3 activation in the presence of Pb, suggesting that Pb may Inhibit Th1 development by enhancing adenylate cyclase activity and elevating the [cAMP]1 level. Similar to Pb, a low concentration (10µM) of dbcAMP inhibited IFN{gamma} production by Th1, which was prevented by IL-12; however, inhibition of protein kinase A activity by KTS720 did not reverse these effects. These results indicate that the environmental toxicant Pb can modify immune reactivities by significantly altering the differentiation of precursor or naive Th cells as well as by directly inhibiting Thl cells and stimulating Th2 Cells.

Key Words: Th1; Th2; cellular activation; cellular differentiation; signal transduction; lead.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Radiat Prot DosimetryHome page
N. Healey
Lead toxicity, vulnerable subpopulations and emergency preparedness
Radiat Prot Dosimetry, June 1, 2009; 134(3-4): 143 - 151.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
M. Valentino, V. Rapisarda, L. Santarelli, M. Bracci, M. Scorcelletti, L. Di Lorenzo, F. Cassano, and L. Soleo
Effect of lead on the levels of some immunoregulatory cytokines in occupationally exposed workers
Human and Experimental Toxicology, July 1, 2007; 26(7): 551 - 556.
[Abstract] [PDF]


Home page
Toxicol SciHome page
Y. Heo, T. K. Mondal, D. Gao, J. Kasten-Jolly, H. Kishikawa, and D. A. Lawrence
Posttranscriptional Inhibition of Interferon-Gamma Production by Lead
Toxicol. Sci., March 1, 2007; 96(1): 92 - 100.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. Gao, J. Kasten-Jolly, and D. A. Lawrence
The Paradoxical Effects of Lead in Interferon-Gamma Knockout BALB/c Mice
Toxicol. Sci., February 1, 2006; 89(2): 444 - 453.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
N. Y. A. Hemdan, F. Emmrich, K. Adham, G. Wichmann, I. Lehmann, A. El-Massry, H. Ghoneim, J. Lehmann, and U. Sack
Dose-Dependent Modulation of the In Vitro Cytokine Production of Human Immune Competent Cells by Lead Salts
Toxicol. Sci., July 1, 2005; 86(1): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C A Hudson, T K Mondal, L Cao, J Kasten-Jolly, V C Huber, and D A Lawrence
The dietary supplement ephedrine induces b-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 mice
Lupus, April 1, 2005; 14(4): 293 - 307.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
Y Heo, B-K Lee, K-D Ahn, and D A Lawrence
Serum IgE elevation correlates with blood lead levels in battery manufacturing workers
Human and Experimental Toxicology, May 1, 2004; 23(5): 209 - 213.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
R R Dietert, J-E Lee, and T L Bunn
Developmental immunotoxicology: emerging issues
Human and Experimental Toxicology, September 1, 2002; 21(9-10): 479 - 485.
[Abstract] [PDF]


Home page
Toxicol SciHome page
J. E. Snyder, N. M. Filipov, P. J. Parsons, and D. A. Lawrence
The Efficiency of Maternal Transfer of Lead and Its Influence on Plasma IgE and Splenic Cellularity of Mice
Toxicol. Sci., September 1, 2000; 57(1): 87 - 94.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.